BPC
GBT

Banque Pictet & Cie’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Banque Pictet & Cie’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-41,898
Closed -$1.34K – 680
2022
Q2 		$1.34K Sell
41,898
-4,037
-9% -$118K 0.01% 376
2022
Q1 		$1.59M Buy
45,935
+1,777
+4% +$53.1K 0.01% 379
2021
Q4 		$1.29M Buy
+44,158
New +$1.37M 0.01% 424

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Banque Pictet & Cie's GBT Position: Q3 2022 in Review

Banque Pictet & Cie sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 41,898 shares — an estimated $1.34K sold.

Banque Pictet & Cie first reported a position in GBT in Q4 2021 and held it in 3 quarters. The position peaked at $1.59M in Q1 2022. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Banque Pictet & Cie reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Banque Pictet & Cie sold 41,898 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $1.34K.
  • Banque Pictet & Cie first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 3 quarters.
  • Banque Pictet & Cie's Global Blood Therapeutics, Inc. position peaked at $1.59M in Q1 2022.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Banque Pictet & Cie's 13F filing for Q3 2022, filed 10 Nov 2022.